Dr. Michael A Belfort, M.D.
Claim this profileTexas Children's Hospital - Pavilion for Women
Studies Twin Placenta
Studies Tethered Cord Syndrome
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Michael A Belfort, M.D. is currently running
Surgical Devices
for Neural Tube Defects
The purpose of the study is to evaluate the safety and efficacy of devices used in patients undergoing fetoscopic neural tube defect repair.
Recruiting1 award N/A
FETO
for Congenital Diaphragmatic Hernia
Congenital diaphragmatic hernia (CDH) occurs when the diaphragm fails to fully fuse and leaves a portal through which abdominal structures can migrate into the thorax. In the more severe cases, the abdominal structures remain in the thoracic cavity and compromise the development of the lungs. Infants born with this defect have a decreased capacity for gas exchange; mortality rates after birth have been reported between 40-60%. Now that CDH can be accurately diagnosed by mid-gestation, a number of strategies have been developed to repair the hernia and promote lung tissue development. Fetal tracheal occlusion (FETO), using a fetoscopically delivered and removed balloon device, has been used to temporarily occlude the trachea and increase lung distension in CDH to allow the lungs to develop and has been shown to increase survival at birth. The role of FETO in the resolution of pulmonary hypertension in fetuses with severe left- and right- sided CDH remains unclear. Our recent observation that FETO is associated with a higher proportion of infants who resolve their pulmonary hypertension by the age of 1 year as compared with those who have not had FETO, is based on a retrospective cohort study, which, as with any such design, has some intrinsic limitations. Thus, a prospective cohort study that is appropriately powered to confirm or disprove this encouraging observation is needed. If our preliminary observation is confirmed, resolution of PH by the age of 1 year could be added to the benefits of the FETO procedure in severe left and right-sided CDH cases. The investigators will perform 40 FETO procedures on fetuses diagnosed prenatally with severe right- or left-sided CDH, and outcome data will be compared with that of a control group of severe right- or left-sided CDH who will not undergo the FETO procedure because of medical or social issues. Because the prevalence of left-sided CDH is higher than right-side CDH, the investigators will perform 25 FETO procedures in left sided CDH and 15 in right-sided CDH, and these outcomes will be compared to a cohort of 40 non FETO cases.
Recruiting1 award N/A9 criteria
More about Michael A Belfort, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael A Belfort, M.D. has experience with
- Fetoscopic Selective Laser Photocoagulation
- Fetoscopy Sets For Anterior And Posterior Placentas
- Modified Surgical Instruments/Devices (Sheaths And Irrigator)
- Fetal Endotracheal Occlusion (FETO)
- Uterine Transplant
- Fetal Repair Of Complex Gastroschisis
Breakdown of trials Michael A Belfort, M.D. has run
Tethered Cord Syndrome
Spina Bifida
Neural Tube Defects
Hypertension
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A Belfort, M.D. specialize in?
Michael A Belfort, M.D. focuses on Twin Placenta and Tethered Cord Syndrome. In particular, much of their work with Twin Placenta has involved treating patients, or patients who are undergoing treatment.
Is Michael A Belfort, M.D. currently recruiting for clinical trials?
Yes, Michael A Belfort, M.D. is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Michael A Belfort, M.D. has studied deeply?
Yes, Michael A Belfort, M.D. has studied treatments such as Fetoscopic Selective Laser Photocoagulation, Fetoscopy Sets for Anterior and Posterior Placentas, Modified Surgical Instruments/Devices (Sheaths and Irrigator).
What is the best way to schedule an appointment with Michael A Belfort, M.D.?
Apply for one of the trials that Michael A Belfort, M.D. is conducting.
What is the office address of Michael A Belfort, M.D.?
The office of Michael A Belfort, M.D. is located at: Texas Children's Hospital - Pavilion for Women, Houston, Texas 77030 United States. This is the address for their practice at the Texas Children's Hospital - Pavilion for Women.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.